pamidronate disodium (pamidronate disodium Hexal) 90 mg/10 mL concentrated injection vial

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

Download 공공 평가 보고서 (PAR)
01-12-2017

유효 성분:

pamidronate disodium, Quantity: 90 mg

제공처:

Sandoz Pty Ltd

INN (국제 이름):

pamidronate disodium

약제 형태:

Injection, concentrated

구성:

Excipient Ingredients: mannitol; sodium hydroxide; phosphoric acid; water for injections

관리 경로:

Intravenous

패키지 단위:

1

수업:

Medicine Registered

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Treatment of conditions associated with increased osteoclast activity: predominantly lytic bone metastases from breast cancer and advanced multiple myeloma; acute management of tumour-induced hypercalcaemia (Hypercalcaemia of malignancy); treatment of symptomatic Paget's disease of bone.

제품 요약:

Visual Identification: Clear, colourless solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2006-01-23